-
01 · How it works
Actuarially underwritten medical receivables.
Apex provides capital against verified medical receivables owed by insurance carriers, government payors (Medicare and Medicaid), and other obligors to healthcare providers, medical lien holders, and related parties. The firm purchases receivables at a discount to their face value, or advances against them, and realizes returns as the underlying claims are processed and paid.
Each receivable is assessed against the payor’s published reimbursement schedule, the claim’s documentation quality, and Apex’s actuarial model for resolution timelines — the same analytical framework applied to the firm’s life settlement portfolio. The asset class requires specialist expertise in medical billing, insurance claims processing, and payor-specific adjudication standards that generalist credit investors do not maintain.
Returns are governed by insurance reimbursement rates, claim resolution timelines, and billing-cycle dynamics — not by interest rate movements, credit spread changes, or equity market conditions. The asset class has structural non-correlation to public markets for the same fundamental reason as life settlements: outcomes are determined by actuarial and administrative factors, not by investor sentiment.
-
02 · Why Uncorrelated
Returns governed by reimbursement schedules, not markets.
No rate sensitivity
Medical receivable returns are determined by insurance carrier reimbursement schedules and claim resolution timelines — not by prevailing interest rates or credit market conditions. A claim’s recovery value is a function of the payor’s contractual obligations, not of the market environment at the time of collection.
Actuarial predictability
Claim resolution timelines follow actuarially predictable patterns by payor type, claim category, and jurisdictional rules. Apex’s underwriting model incorporates these patterns to set pricing against conservative recovery assumptions — the same approach applied in the life settlement portfolio.
Structural demand
Healthcare providers require capital against receivables that may take months to be reimbursed by insurance carriers. This structural need exists regardless of the economic cycle, providing a consistent origination pipeline independent of credit market conditions.
Verified receivables. Structured returns.
-
03 · Investment Process
From sourcing to collection.
Apex’s healthcare receivables process applies the same actuarial discipline that underpins the life settlement strategy — medical expertise, conservative pricing assumptions, and active management through to realization.
-
01 · Sourcing
Origination
Healthcare providers, medical lien holders, and related parties are sourced through Apex’s medical-legal origination network and established intermediary relationships. Each receivable pool is evaluated against Apex’s criteria for payor quality, claim age, documentation completeness, and jurisdictional enforceability before underwriting resources are committed.
-
02 · Underwriting
Medical & Actuarial Analysis
Apex’s medical and actuarial team assesses each receivable against the relevant payor’s reimbursement schedule, the claim’s clinical documentation, historic settlement rates for the applicable claim category, and Apex’s actuarial model for resolution timelines. Pricing is set against conservative recovery assumptions — consistent with the underwriting discipline applied in the life settlement portfolio.
-
03 · Servicing & Collection
Active Management to Realization
Following acquisition or advance, Apex manages the claim lifecycle through to collection — coordinating with payors, adjusters, and legal counsel as required by the claim category and jurisdiction. Portfolio performance is monitored against underwriting assumptions throughout the hold period, with investor reporting provided on a regular basis.
-
04 · Why Apex
The same specialist discipline applied to a new market.
Apex’s competitive advantage in healthcare receivables is the direct transfer of the actuarial and medical underwriting capability developed in the life settlement strategy to a structurally similar but distinct asset class. The firm’s in-house medical expertise, actuarial modelling, and legal capability — all developed and maintained for the life settlement portfolio — are directly applicable to the underwriting of medical receivables.
This is not a new discipline for the firm. It is the same framework — actuarial assessment of contractual obligations, conservative pricing against recovery assumptions, active management through to realization — deployed in a market where the obligor is an insurance carrier rather than a life insurance policyholder.
Healthcare receivables expand Apex’s uncorrelated yield platform into a fourth distinct market while drawing on the same specialist capabilities that define the firm’s competitive position in life settlements.